<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01174329</url>
  </required_header>
  <id_info>
    <org_study_id>1234</org_study_id>
    <nct_id>NCT01174329</nct_id>
  </id_info>
  <brief_title>Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation</brief_title>
  <acronym>SALELECTROSTIM</acronym>
  <official_title>Difference in Salivary Flow in Patients With Salivary Gland Hypofunction of the Following Application of Neuro-electrostimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de Nuevo Leon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de Nuevo Leon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate with clinical parameters the performance of
      Saliwell Crown as a neuro-electrostimulator of the submandibular and sublingual salivary
      glands in hypofunction status due to polypharmacy or Sjögren's Syndrome in patients with
      symptoms of xerostomia.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>self-reported xerostomia</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Xerostomia</condition>
  <condition>Polypharmacy</condition>
  <condition>Sjögren's Syndrome</condition>
  <arm_group>
    <arm_group_label>Patient-regulated neuro-electrostimulation by &quot;Saliwell Crown&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient regulated (by a remote control) neuro-electrostimulation by &quot;Saliwell Crown&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Automatic neuro-electrostimulation by &quot;Saliwell Crown&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No remote control used</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automatic neuro-electrostimulation by &quot;Saliwell Crown&quot;</intervention_name>
    <description>Continuous stimulation of the lingual nerve by &quot;Saliwell Crown&quot;</description>
    <arm_group_label>Automatic neuro-electrostimulation by &quot;Saliwell Crown&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient-regulated neuro-electrostimulation by &quot;Saliwell Crown&quot;</intervention_name>
    <description>On-demand stimulation of the lingual nerveby &quot;Saliwell Crown&quot;</description>
    <arm_group_label>Patient-regulated neuro-electrostimulation by &quot;Saliwell Crown&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age range between 18 and 75 years of age

          -  Clinical symptoms of xerostomia

          -  Difference in whole salivary flow between resting and stimulating conditions

          -  Patient ASA type I to III

          -  Absence of at least one mandibular third molar inferior, but at least partially
             dentated in the mandible

        Exclusion Criteria:

          -  Patients with antimicrobial treatments in the three previous months

          -  Smokers

          -  Intake of bisphosphonates

          -  Limitation of mandibular opening

          -  Interoclusal distance smaller than 10 millimetres

          -  Lack of adequate bone availability for implant placement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria G Chapa Arizpe, Dr.</last_name>
    <phone>+52 81 8329 4230</phone>
    <email>maiech@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>C.D. Especialidad de Periodoncia</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María G Chapa Arizpe, Dr.</last_name>
      <phone>+52 81 83 46 62 62</phone>
      <email>maiech@hotmail.com</email>
    </contact>
    <contact_backup>
      <phone>+52 81 83 29 42 50</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2010</study_first_submitted>
  <study_first_submitted_qc>August 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2010</study_first_posted>
  <last_update_submitted>August 17, 2010</last_update_submitted>
  <last_update_submitted_qc>August 17, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Mario Cesar Salinas Carmona</name_title>
    <organization>Universidad Autónoma de Nuevo León</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

